Logo image of CNM

CORE & MAIN INC-CLASS A (CNM) Stock Fundamental Analysis

USA - NYSE:CNM - US21874C1027 - Common Stock

49.76 USD
+1.09 (+2.24%)
Last: 9/15/2025, 4:23:54 PM
49.76 USD
0 (0%)
After Hours: 9/15/2025, 4:23:54 PM
Fundamental Rating

5

Taking everything into account, CNM scores 5 out of 10 in our fundamental rating. CNM was compared to 50 industry peers in the Trading Companies & Distributors industry. While CNM belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CNM has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year CNM was profitable.
CNM had a positive operating cash flow in the past year.
CNM had positive earnings in each of the past 5 years.
Of the past 5 years CNM 4 years had a positive operating cash flow.
CNM Yearly Net Income VS EBIT VS OCF VS FCFCNM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

With a decent Return On Assets value of 6.83%, CNM is doing good in the industry, outperforming 68.00% of the companies in the same industry.
CNM's Return On Equity of 22.85% is amongst the best of the industry. CNM outperforms 84.00% of its industry peers.
CNM's Return On Invested Capital of 10.97% is fine compared to the rest of the industry. CNM outperforms 70.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNM is above the industry average of 10.24%.
Industry RankSector Rank
ROA 6.83%
ROE 22.85%
ROIC 10.97%
ROA(3y)7.26%
ROA(5y)5.33%
ROE(3y)23.57%
ROE(5y)17.76%
ROIC(3y)13.05%
ROIC(5y)10.52%
CNM Yearly ROA, ROE, ROICCNM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

With a decent Profit Margin value of 5.57%, CNM is doing good in the industry, outperforming 66.00% of the companies in the same industry.
CNM's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 9.44%, CNM is doing good in the industry, outperforming 66.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CNM has grown nicely.
CNM has a Gross Margin (26.67%) which is in line with its industry peers.
CNM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.44%
PM (TTM) 5.57%
GM 26.67%
OM growth 3Y4.39%
OM growth 5Y16.07%
PM growth 3Y18.52%
PM growth 5Y35.35%
GM growth 3Y1.32%
GM growth 5Y2.7%
CNM Yearly Profit, Operating, Gross MarginsCNM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CNM is creating some value.
The number of shares outstanding for CNM has been reduced compared to 1 year ago.
CNM has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CNM is higher compared to a year ago.
CNM Yearly Shares OutstandingCNM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CNM Yearly Total Debt VS Total AssetsCNM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.32 indicates that CNM is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.32, CNM is in line with its industry, outperforming 54.00% of the companies in the same industry.
The Debt to FCF ratio of CNM is 4.00, which is a neutral value as it means it would take CNM, 4.00 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.00, CNM is in the better half of the industry, outperforming 66.00% of the companies in the same industry.
CNM has a Debt/Equity ratio of 1.18. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.18, CNM is doing worse than 66.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 4
Altman-Z 3.32
ROIC/WACC1.11
WACC9.91%
CNM Yearly LT Debt VS Equity VS FCFCNM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

CNM has a Current Ratio of 2.25. This indicates that CNM is financially healthy and has no problem in meeting its short term obligations.
CNM has a Current ratio (2.25) which is in line with its industry peers.
A Quick Ratio of 1.30 indicates that CNM should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.30, CNM perfoms like the industry average, outperforming 56.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.3
CNM Yearly Current Assets VS Current LiabilitesCNM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

CNM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.43%, which is quite good.
Measured over the past years, CNM shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.38% on average per year.
Looking at the last year, CNM shows a quite strong growth in Revenue. The Revenue has grown by 11.02% in the last year.
Measured over the past years, CNM shows a quite strong growth in Revenue. The Revenue has been growing by 17.04% on average per year.
EPS 1Y (TTM)10.43%
EPS 3Y44.94%
EPS 5Y64.38%
EPS Q2Q%29.85%
Revenue 1Y (TTM)11.02%
Revenue growth 3Y14.14%
Revenue growth 5Y17.04%
Sales Q2Q%6.57%

3.2 Future

Based on estimates for the next years, CNM will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.23% on average per year.
CNM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.74% yearly.
EPS Next Y9.09%
EPS Next 2Y11.84%
EPS Next 3Y10.23%
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2Y3.8%
Revenue Next 3Y3.74%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CNM Yearly Revenue VS EstimatesCNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
CNM Yearly EPS VS EstimatesCNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.59, CNM is valued on the expensive side.
Based on the Price/Earnings ratio, CNM is valued a bit cheaper than 72.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. CNM is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 17.30, which indicates a rather expensive current valuation of CNM.
Based on the Price/Forward Earnings ratio, CNM is valued a bit cheaper than 70.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. CNM is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.59
Fwd PE 17.3
CNM Price Earnings VS Forward Price EarningsCNM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CNM's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNM indicates a somewhat cheap valuation: CNM is cheaper than 78.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.42
EV/EBITDA 12.79
CNM Per share dataCNM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CNM does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CNM may justify a higher PE ratio.
PEG (NY)2.15
PEG (5Y)0.3
EPS Next 2Y11.84%
EPS Next 3Y10.23%

More info and screens

0

5. Dividend

5.1 Amount

CNM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORE & MAIN INC-CLASS A

NYSE:CNM (9/15/2025, 4:23:54 PM)

After market: 49.76 0 (0%)

49.76

+1.09 (+2.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)09-09 2025-09-09/bmo
Earnings (Next)12-02 2025-12-02/bmo
Inst Owners112.46%
Inst Owner Change-1.5%
Ins Owners0.56%
Ins Owner Change4.04%
Market Cap9.82B
Analysts76.67
Price Target60.84 (22.27%)
Short Float %5.57%
Short Ratio5.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.35%
Min EPS beat(2)5.47%
Max EPS beat(2)9.23%
EPS beat(4)4
Avg EPS beat(4)6.98%
Min EPS beat(4)0.71%
Max EPS beat(4)12.5%
EPS beat(8)7
Avg EPS beat(8)3.71%
EPS beat(12)11
Avg EPS beat(12)5.9%
EPS beat(16)15
Avg EPS beat(16)11.78%
Revenue beat(2)1
Avg Revenue beat(2)-0.19%
Min Revenue beat(2)-3.06%
Max Revenue beat(2)2.69%
Revenue beat(4)3
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)-0.64%
Revenue beat(12)5
Avg Revenue beat(12)-0.44%
Revenue beat(16)9
Avg Revenue beat(16)2.34%
PT rev (1m)-8.14%
PT rev (3m)-0.92%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)-0.77%
EPS NY rev (1m)-0.36%
EPS NY rev (3m)1.92%
Revenue NQ rev (1m)-1.41%
Revenue NQ rev (3m)-2.41%
Revenue NY rev (1m)-1.21%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE 19.59
Fwd PE 17.3
P/S 1.27
P/FCF 17.42
P/OCF 16.21
P/B 5.21
P/tB N/A
EV/EBITDA 12.79
EPS(TTM)2.54
EY5.1%
EPS(NY)2.88
Fwd EY5.78%
FCF(TTM)2.86
FCFY5.74%
OCF(TTM)3.07
OCFY6.17%
SpS39.2
BVpS9.55
TBVpS-4.45
PEG (NY)2.15
PEG (5Y)0.3
Profitability
Industry RankSector Rank
ROA 6.83%
ROE 22.85%
ROCE 14.09%
ROIC 10.97%
ROICexc 11.03%
ROICexgc 23.74%
OM 9.44%
PM (TTM) 5.57%
GM 26.67%
FCFM 7.29%
ROA(3y)7.26%
ROA(5y)5.33%
ROE(3y)23.57%
ROE(5y)17.76%
ROIC(3y)13.05%
ROIC(5y)10.52%
ROICexc(3y)13.27%
ROICexc(5y)10.76%
ROICexgc(3y)30.58%
ROICexgc(5y)28.28%
ROCE(3y)16.76%
ROCE(5y)13.51%
ROICexcg growth 3Y-1.87%
ROICexcg growth 5Y6.48%
ROICexc growth 3Y6.77%
ROICexc growth 5Y19.1%
OM growth 3Y4.39%
OM growth 5Y16.07%
PM growth 3Y18.52%
PM growth 5Y35.35%
GM growth 3Y1.32%
GM growth 5Y2.7%
F-Score6
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 4
Debt/EBITDA 2.41
Cap/Depr 21.54%
Cap/Sales 0.54%
Interest Coverage 4.84
Cash Conversion 65.44%
Profit Quality 130.86%
Current Ratio 2.25
Quick Ratio 1.3
Altman-Z 3.32
F-Score6
WACC9.91%
ROIC/WACC1.11
Cap/Depr(3y)20.09%
Cap/Depr(5y)16.28%
Cap/Sales(3y)0.48%
Cap/Sales(5y)0.43%
Profit Quality(3y)174.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.43%
EPS 3Y44.94%
EPS 5Y64.38%
EPS Q2Q%29.85%
EPS Next Y9.09%
EPS Next 2Y11.84%
EPS Next 3Y10.23%
EPS Next 5YN/A
Revenue 1Y (TTM)11.02%
Revenue growth 3Y14.14%
Revenue growth 5Y17.04%
Sales Q2Q%6.57%
Revenue Next Year3.03%
Revenue Next 2Y3.8%
Revenue Next 3Y3.74%
Revenue Next 5YN/A
EBIT growth 1Y3.25%
EBIT growth 3Y19.16%
EBIT growth 5Y35.85%
EBIT Next Year34.31%
EBIT Next 3Y16.22%
EBIT Next 5YN/A
FCF growth 1Y-32.7%
FCF growth 3YN/A
FCF growth 5Y24.92%
OCF growth 1Y-29.78%
OCF growth 3YN/A
OCF growth 5Y24.63%